03:40:15 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-23 Kvartalsrapport 2024-Q3
2024-07-15 Kvartalsrapport 2024-Q2
2024-05-10 Ordinarie utdelning ALIF B 0.50 SEK
2024-05-08 Årsstämma 2024
2024-04-24 Kvartalsrapport 2024-Q1
2024-02-02 Bokslutskommuniké 2023
2023-10-26 Kvartalsrapport 2023-Q3
2023-07-14 Kvartalsrapport 2023-Q2
2023-05-05 Ordinarie utdelning ALIF B 1.20 SEK
2023-05-04 Årsstämma 2023
2023-04-26 Kvartalsrapport 2023-Q1
2023-02-02 Bokslutskommuniké 2022
2022-10-27 Kvartalsrapport 2022-Q3
2022-07-15 Kvartalsrapport 2022-Q2
2022-05-06 Ordinarie utdelning ALIF B 2.00 SEK
2022-05-05 Årsstämma 2022
2022-04-28 Kvartalsrapport 2022-Q1
2022-02-04 Bokslutskommuniké 2021
2021-10-22 Kvartalsrapport 2021-Q3
2021-07-15 Kvartalsrapport 2021-Q2
2021-05-06 Ordinarie utdelning ALIF B 1.50 SEK
2021-05-05 Årsstämma 2021
2021-04-28 Kvartalsrapport 2021-Q1
2021-02-03 Bokslutskommuniké 2020
2020-11-20 Bonusutdelning ALIF B 0.5
2020-11-19 Extra Bolagsstämma 2020
2020-10-22 Kvartalsrapport 2020-Q3
2020-07-17 Kvartalsrapport 2020-Q2
2020-05-27 Split ALIF B 1:4
2020-05-08 Ordinarie utdelning ALIF B 0.00 SEK
2020-05-07 Årsstämma 2020
2020-04-28 Kvartalsrapport 2020-Q1
2020-02-06 Bokslutskommuniké 2019
2019-11-07 Kvartalsrapport 2019-Q3
2019-07-12 Kvartalsrapport 2019-Q2
2019-05-10 Ordinarie utdelning ALIF B 2.20 SEK
2019-05-09 Kvartalsrapport 2019-Q1
2019-05-09 Årsstämma 2019
2019-02-12 Bokslutskommuniké 2018
2018-12-20 Extra Bolagsstämma 2018
2018-11-07 Kvartalsrapport 2018-Q3
2018-07-13 Kvartalsrapport 2018-Q2
2018-06-01 Ordinarie utdelning ALIF B 2.20 SEK
2018-05-31 Årsstämma 2018
2018-04-27 Kvartalsrapport 2018-Q1
2018-02-13 Bokslutskommuniké 2017
2017-10-26 Kvartalsrapport 2017-Q3
2017-07-17 Kvartalsrapport 2017-Q2
2017-05-30 Ordinarie utdelning ALIF B 1.50 SEK
2017-05-29 Årsstämma 2017
2017-04-28 Kvartalsrapport 2017-Q1
2017-02-16 Bokslutskommuniké 2016
2016-10-27 Kvartalsrapport 2016-Q3
2016-09-02 Ordinarie utdelning ALIF B 0.00 SEK
2016-09-01 Årsstämma 2016
2016-07-15 Kvartalsrapport 2016-Q2

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
AddLife är en koncern med verksamhet inom life-science sektorn. Inom koncernen återfinns specialisering främst mot diagnostik, medicinteknik och biomedicinsk forskning. Verksamhet innehas främst i Norden och Baltikum med kunder inom vård och omsorg, samt forskningsinstitut. Addlife bildades under 2015 vid en avknoppning ur Addtech koncernen. Bolaget har sitt huvudkontor i Stockholm.
2019-11-25 10:00:00

AddLife's Norwegian subsidiary Hepro has won a major procurement contract in welfare technology with Oslo Municipality. The order, which is worth about NOK 120 million, is for high-quality and effective monitoring of healthcare and social services with special consideration for user privacy. The welfare technology that Hepro will deliver involves a digital platform, as well as assistive devices for home use as well as for nursing homes and senior housing facilities. AddLife acquired Hepro in February 2017.

Oslo Municipality set high demands for the supplier that would provide welfare technology to the elderly residents of the municipality. The goal of the solution is to increase efficiency and quality of care, reduce the risk of accidents and injuries, while maintaining the quality of life and privacy of users.
Hepro offers a broad portfolio of products and services in the field of welfare technology that includes supplying both hardware and software, as well as installation and service. The functionality of the solution can be expanded to be adapted to meet the increased need for help among users. In addition to technology that monitors potential risks or accidents in the home, Hepro can also provide assistive devices for purposes such as moving around within and outside the home.
- "We are proud that Oslo Municipality has entrusted us with this contract. As a developer and provider of welfare technology, our driving force is always to secure products and services that enable more people to feel safe either at home or in senior housing facilities. Safety  includes the possibility to expand the solution as their need for help increases" says Kurt Kristoffersen, CEO of Hepro AS.
Hepro will deliver welfare technology to Oslo Municipality over a two-year period with the option to extend the contract for two years. The value of the contract is estimated at about NOK 120 million.
- "Our subsidiaries throughout Europe work every day to add value for customers in the healthcare sector. The products and services that our group can provide will help to achieve safe and efficient care for providers, patients and society at large. Quality is a key factor in our sector. The contract from Oslo Municipality is proof that our companies live up to the high standards of our customers," says Kristina Willgard, CEO of AddLife.

Stockholm 30 April 2019
AddLife AB (publ.)
For further information, please contact
Kristina Willgård, CEO, AddLife AB, +46-705 10 12 23
Kurt Kristoffersen, MD, Hepro A/S, +47 93 29 30 30

AddLife is an independent player in Life Science that offers high-quality products, services and advice to both the private and public sector, mainly in the Nordic region. AddLife has around 900 employees in around 40 subsidiaries that operate under their own brands. The Group has net sales of around SEK 3.2 billion. AddLife shares are listed on NASDAQ Stockholm.
This information was submitted for publication on 25 November 2019 at 10:00 CET.